Vivitrol works by blocking your brain’s mu-opioid receptors, cutting off the rewarding effects of alcohol and opioids that fuel addiction. You’ll receive a 380 mg extended-release injection once a month, giving you continuous receptor coverage for about 30 days. This lowers your cravings and weakens the pleasure tied to drinking and opioid use. In trials, users saw a 55% reduction in craving scores. Understanding how it compares to other treatments helps you decide what’s right.
What Is Vivitrol and How Does It Work?

Vivitrol is the brand name for naltrexone, a non-addictive, non-narcotic medication delivered as an extended-release intramuscular injection once a month. It’s an opioid antagonist, which means it blocks opioid receptors, particularly mu-opioid receptors, rather than activating them. Because Vivitrol doesn’t stimulate these receptors, it won’t produce euphoria, sedation, or a high.
When naltrexone binds to opioid receptor sites, it prevents other substances from attaching, interrupting the brain’s reinforcement response. This reduces the rewarding effects tied to both alcohol and opioids, lowering cravings. It also impacts the HPA axis to suppress the feelings of relaxation that come from drinking. The extended-release formulation keeps Vivitrol active for weeks after a single injection, so you don’t need a daily dose.
Vivitrol isn’t a withdrawal treatment. You’ll typically start it only after you’ve stopped using the targeted substance.
How Vivitrol Blocks Opioid Cravings and Relapse
When you receive Vivitrol, its extended-release naltrexone binds your mu-opioid receptors and holds them blocked for about a month. With those receptors occupied, opioids like heroin, fentanyl, and prescription pills can’t produce the euphoria, sedation, or pain relief that reinforce repeat use. By eliminating that high after detox, Vivitrol removes the incentive to return to opioids and helps prevent relapse. Because it is administered once a month via intramuscular injection, Vivitrol provides continuous support without the need for daily compliance.
Blocking Mu-Opioid Receptors
Because Vivitrol contains naltrexone, an opioid antagonist with high affinity for the mu-opioid receptor, it blocks opioid effects through competitive binding. By blocking mu-opioid receptors, it prevents opioids from activating the receptor and producing their usual effects. The medication has little, if any, opioid agonist activity, so it doesn’t stimulate the receptor the way opioids do. By occupying these receptor sites, naltrexone also blocks endogenous opioid peptides along with exogenous opioids.
This receptor blockade disrupts the reward signaling that reinforces opioid use, which reduces cravings over time. As you lose that reward association, opioid use loses its incentive value. Delivered as a monthly injection, Vivitrol maintains continuous receptor coverage for about 30 days, sustaining a stable pharmacologic barrier against opioid re-use between doses. Naltrexone also alters the hypothalamic-pituitary-adrenal axis to suppress ethanol consumption, supporting its use in alcohol use disorder.
Eliminating the Opioid High
Once naltrexone occupies the mu-opioid receptors, any opioid you take can’t bind effectively, so the euphoric “high” simply doesn’t materialize. This blockade lasts up to one month from a single injection, providing continuous receptor coverage. Because Vivitrol is not addictive, it controls opioid and alcohol use disorder without producing dependence or a high of its own. You must detox first, staying opioid-free for 7 to 10 days, or the injection can trigger withdrawal.
| Mechanism | Effect | Clinical Relevance |
|---|---|---|
| Receptor blockade | Opioids can’t bind | Eliminates euphoria |
| Monthly dosing | Continuous coverage | No daily dose needed |
| Non-agonist action | Not addictive | Avoids new dependence |
| Required detox | Prevents withdrawal | Guarantees safe start |
Preventing Relapse After Detox
After detox clears acute physical dependence, you still face cravings and conditioned triggers that can drive relapse, and that’s where Vivitrol does its work. Once you’ve been opioid-free for 7 to 10 days, your first injection establishes a long-acting blockade, binding opioid receptors for about a month without activating them. This weakens the brain’s learned association between opioid use and reward, reducing the reinforcement that drives relapse.
The evidence is measurable. In a 24-week trial of recently detoxed outpatients, 36% receiving Vivitrol plus counseling stayed completely abstinent during Weeks 5, 24, with a median 90% of weeks abstinent versus 35% on placebo. Craving scores dropped 55% from baseline, while placebo rose 3%. You’re not relying on willpower alone, you’ve got a pharmacologic barrier supporting your recovery.
How Vivitrol Reduces the Reward From Alcohol
When you drink, alcohol triggers the release of endorphins that bind to opioid receptors and produce a pleasurable reward signal. Vivitrol occupies those receptors, so it blocks this endorphin activity and weakens the reward you’d normally feel from drinking. By disrupting that reinforcement, it interrupts the cycle that links alcohol to pleasure and keeps repeated drinking compelling.
Blocking Endorphin Reward Signals
Although alcohol doesn’t act on opioid receptors directly, it triggers the release of endorphins, which then bind to those receptors and drive much of alcohol’s rewarding effect. Vivitrol delivers naltrexone, a competitive opioid receptor antagonist that occupies your mu-opioid receptors without activating them. When endorphins flood these receptors after you drink, naltrexone blocks them from binding, so they can’t trigger the usual reward response.
This receptor blockade dampens the pleasure, euphoria, and reinforcement you’d normally feel from alcohol. The core effect isn’t sedation or intoxication, it’s the interruption of reward signaling at the receptor level.
Weakening the Drinking Cycle
Because alcohol’s rewarding effects depend partly on opioid-receptor signaling, Vivitrol weakens the drinking cycle at its source. As the extended-release form of naltrexone, it attaches to the opioid receptors involved in alcohol’s rewarding effects, lowering the pleasurable response you’d normally feel from drinking. With less reward, your brain receives weaker reinforcement to repeat the behavior, and that reduced reinforcement is linked to lower craving intensity over time.
This effect shows up in clinical data. In one cited study, heavy drinking days dropped to 11.7% with injectable naltrexone versus 25.3% with placebo. The strongest effect was on reducing heavy drinking rather than guaranteeing full abstinence.
Keep in mind that craving reduction is gradual, not immediate, and response varies by person, so consistent use matters during recovery.
Vivitrol vs. Suboxone: Which Works Better?

How do Vivitrol and Suboxone actually differ? Vivitrol contains naltrexone, an opioid antagonist that blocks receptors, so you get no euphoria or pain relief from opioids. Suboxone contains buprenorphine, a partial agonist that activates receptors enough to ease withdrawal and cravings. In one multisite randomized trial, 57% relapsed on Suboxone versus 65% on Vivitrol, a statistically significant difference, and Suboxone participants averaged 10 negative toxicology screens versus 4. Suboxone holds an advantage in outpatient settings where you need fast initiation, since Vivitrol requires 7, 14 days of full detox first and can trigger precipitated withdrawal. Vivitrol fits better after detox when you want opioid blockade without agonist activity, and it’s also approved for alcohol use disorder. Your provider can determine which suits your situation.
When to Start Vivitrol After Detox
Since Vivitrol requires full detox before that first injection, timing matters more than with agonist options like Suboxone. You must be completely opioid-free before your first dose, or naltrexone can trigger sudden, dangerous withdrawal. For short-acting opioids, you’ll typically wait at least 7 days after last use. Long-acting opioids clear more slowly, so 10 to 14 days is commonly recommended. For alcohol dependence, you should start after drinking has stopped and detox is complete, though no fixed day count applies. Your provider confirms readiness before administering the monthly intramuscular injection. Careful timing keeps that first dose both safe and effective. If withdrawal risk remains high, you may need to delay initiation. Starting after detox supports relapse prevention throughout early recovery and ongoing treatment.
What to Expect From Monthly Vivitrol Injections

Each Vivitrol injection delivers a standard 380 mg dose, given once every 4 weeks by a healthcare professional rather than self-administered. You’ll receive a 4 mL deep gluteal intramuscular injection, with the provider typically alternating buttocks at each visit. As an extended-release microsphere formulation of naltrexone, the medication releases continuously over the dosing interval. After your first injection, onset of effects can begin within several hours, though full effect may not occur for 2 to 3 days. Drug concentrations begin declining about 14 days after dosing, but measurable levels can persist beyond one month, with effects lasting roughly 30 days. If you miss an appointment, schedule the next injection as soon as possible. Nausea after the first injection becomes less likely with later injections.
Side Effects and Safety Risks to Know
While Vivitrol is generally well tolerated, you should understand its potential side effects and safety risks before starting treatment. The most common reactions include nausea, headache, dizziness, sleepiness, insomnia, decreased appetite, and injection-site pain or tenderness. More serious concerns require prompt medical attention:
Understanding Vivitrol’s side effects and safety risks before treatment helps you recognize concerns early and seek prompt medical attention.
- Liver risks: elevated enzymes, hepatitis, and rarely liver failure
- Mental health: depression and suicidal thoughts or behaviors
- Injection-site reactions: infection, tissue death (necrosis), and scarring
- Allergic reactions: rash, hives, facial swelling, or trouble breathing
You also face an increased risk of opioid overdose if you use opioids to overcome the blockade or after its effect fades. Because drowsiness and fainting can occur, avoid driving until you know how Vivitrol affects you. Report any concerning symptoms to your provider immediately.
Call Today and Explore Safer Recovery Options
Medication-assisted recovery can offer powerful support when guided by the right professional team. At The Villa Treatment Center in Woodland Hills, CA, our caring professionals provide trusted Drug Addiction Treatment with understanding and a plan shaped around you. Call +1-818-639-7160 today and take the first step toward lasting recovery.
Frequently Asked Questions
How Much Does Vivitrol Cost, and Does Insurance Cover It?
Without insurance, you’ll typically pay about $1,000 to $1,500 per monthly injection, though some pharmacies list prices over $2,000. Many insurance plans, including Medicaid in all 50 states, cover Vivitrol under medical or prescription benefits, though prior authorization may apply. You can lower costs further through the VIVITROL Co-pay Savings Program, which offers up to $500 per prescription. If you’re uninsured, income-based patient assistance may reduce your cost considerably.
Can I Take Vivitrol While Pregnant or Breastfeeding?
You can use Vivitrol while pregnant or breastfeeding, but only when benefits clearly outweigh risks, since human data are insufficient. For opioid use disorder in pregnancy, CDC guidance prefers methadone or buprenorphine first. If you’re at high relapse risk, your provider may continue naltrexone after discussing risks and obtaining consent. Vivitrol passes into breast milk, but infant effects aren’t well established. You’ll need an individualized risk-benefit review with your provider.
What Happens if I Need Surgery While on Vivitrol?
If you need surgery while on Vivitrol, tell your surgeon, anesthesiologist, and prescriber the date of your last injection. Because Vivitrol blocks opioid pain medicines, you’ll likely need non-opioid options or regional anesthesia. For elective procedures, your team may schedule surgery about a month after your last dose. Don’t try opioids to override the blockade, that’s dangerous and can cause overdose, especially as the medication fades and your opioid sensitivity rises.
How Long Should I Stay on Vivitrol Treatment?
You’ll typically stay on Vivitrol for at least one year, though there’s no universal stop date. Your duration depends on your recovery progress, relapse risk, and treatment response. Many programs continue injections while they’re still supporting your stability and reducing cravings. Some people need only a few months; others benefit from longer use. Don’t stop without a plan, since relapse and overdose risks remain. Your provider will individualize this decision with you.
Can I Drink Alcohol or Use Opioids After Stopping Vivitrol?
Once Vivitrol clears your system, it no longer blocks opioids or reduces alcohol cravings, so neither is safe in recovery terms. Your relapse risk remains, and your opioid tolerance may be lower, raising overdose risk. There’s no clearly defined waiting period after stopping, so don’t restart opioids without clinician guidance. Alcohol isn’t recommended either. Keep up counseling and relapse-prevention strategies, and talk with your provider before making any changes.






